Our products are for in vitro research use only, not for clinical diagnosis
-
ProductWe specialize in the development, production and sales of ELISA kits, antibodies, recombinant proteins and related reagents for the international market.
-
ResearchThe company has mature biological technologies such as molecular biology technology, immunology technology, protein expression and purification technology, antibody screening and preparation.
-
ServicesWith excellent products and perfect service system, the company is favored and recognized by the majority of domestic and foreign customers.
-
NewsThe company would like to be your research helper and professional manufacturer.
-
AboutLocated in China Optics Valley Biological City, the company has a modern R&D center and a standard production workshop, and has passed the overall ISO 9001:2022 quality management system certification.
2022-06-21
BSG antibodies have transendothelial cell drug delivery capability
The blood-brain barrier (BBB) poses a challenge to antibody-based brain therapies and is a major barrier to the successful application of biotherapeutics in the treatment of brain diseases. Since only a small percentage of monoclonal antibodies (mAbs) are able to penetrate the blood-brain barrier, large doses of therapeutic drugs are required to elicit drug effects.
2022-05-20
IL-17 stimulation induces NOTCH1 activation in OPC, leading to Th17-mediated demyelinating disease
Multiple sclerosis is a disease of central nervous demyelination that is more common in Western countries and is increasing in number in China every year. The disease is usually characterized by a remitting, relapsing course, with a predilection for the optic nerve, spinal cord and brainstem. There is no better treatment for this disease, and the available drugs can only alleviate and slow down the disease process.
Contact Us
Phone： 400-027-8858
Fax： 027-86627593
Address：A101, Building C1, Bio City, No.666 Gaoxin Avenue, East Lake New Technology Development Zone, Wuhan
E-mail：reivaa@reivaa.com
Copyright © 2023Wuhan Reivaa Biotech Co., Ltd.
SEO | Business license | IPv6 access support
IPv6 access support
WhatsApp：400-027-8858
Add：A101, Building C1, Bio City, No.666 Gaoxin Avenue, East Lake New Technology Development Zone, Wuhan
E-mail： mail@reivaa.com
We will give you feedback in time